Tempus AI (NASDAQ:TEM) Shares Gap Down – Time to Sell?

Tempus AI, Inc. (NASDAQ:TEM) shares gapped down before the market opened on Monday . The stock had previously closed at $52.47, but opened at $49.78. Tempus AI shares last traded at $47.8080, with a volume of 2,257,086 shares changing hands.

Wall Street Analyst Weigh In

Several brokerages recently commented on TEM. Wall Street Zen lowered shares of Tempus AI from a “hold” rating to a “sell” rating in a research report on Saturday, July 4th. Jefferies Financial Group assumed coverage on shares of Tempus AI in a research report on Monday, April 13th. They set an “underperform” rating and a $35.00 target price on the stock. BTIG Research restated a “buy” rating and set a $80.00 price target on shares of Tempus AI in a research note on Monday, June 1st. TD Cowen reaffirmed a “buy” rating on shares of Tempus AI in a report on Wednesday. Finally, Needham & Company LLC reiterated a “buy” rating and set a $75.00 price objective on shares of Tempus AI in a research note on Monday, June 1st. Nine analysts have rated the stock with a Buy rating, four have assigned a Hold rating and two have issued a Sell rating to the company. Based on data from MarketBeat.com, Tempus AI presently has an average rating of “Hold” and an average target price of $68.92.

Tempus AI Stock Down 9.1%

The company has a quick ratio of 3.15, a current ratio of 3.31 and a debt-to-equity ratio of 2.96. The company has a market capitalization of $8.57 billion, a price-to-earnings ratio of -27.78 and a beta of 3.46. The business’s 50-day moving average is $51.60 and its 200-day moving average is $54.00.

Tempus AI (NASDAQ:TEM) last announced its quarterly earnings results on Tuesday, May 5th. The company reported ($0.13) earnings per share for the quarter, topping the consensus estimate of ($0.21) by $0.08. The company had revenue of $348.12 million for the quarter, compared to the consensus estimate of $345.44 million. Tempus AI had a negative return on equity of 53.83% and a negative net margin of 22.20%.The firm’s revenue for the quarter was up 36.1% compared to the same quarter last year. During the same period last year, the firm earned ($0.24) EPS. As a group, equities analysts predict that Tempus AI, Inc. will post -1.35 earnings per share for the current year.

Insider Transactions at Tempus AI

In related news, CEO Ryan Fukushima sold 33,284 shares of the firm’s stock in a transaction dated Wednesday, July 8th. The stock was sold at an average price of $57.39, for a total transaction of $1,910,168.76. Following the sale, the chief executive officer directly owned 167,763 shares of the company’s stock, valued at $9,627,918.57. This trade represents a 16.56% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, CEO Eric P. Lefkofsky sold 166,250 shares of the business’s stock in a transaction that occurred on Monday, June 29th. The shares were sold at an average price of $57.48, for a total value of $9,556,050.00. Following the completion of the transaction, the chief executive officer directly owned 8,775,283 shares of the company’s stock, valued at $504,403,266.84. The trade was a 1.86% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Over the last ninety days, insiders have sold 616,043 shares of company stock valued at $31,748,593. 24.26% of the stock is owned by insiders.

Hedge Funds Weigh In On Tempus AI

Institutional investors have recently made changes to their positions in the company. Handelsbanken Fonder AB increased its holdings in shares of Tempus AI by 4.1% during the 2nd quarter. Handelsbanken Fonder AB now owns 32,900 shares of the company’s stock valued at $1,906,000 after purchasing an additional 1,300 shares in the last quarter. CoreCap Advisors LLC boosted its holdings in Tempus AI by 293.4% during the second quarter. CoreCap Advisors LLC now owns 1,019 shares of the company’s stock worth $59,000 after buying an additional 760 shares in the last quarter. NewEdge Advisors LLC grew its position in Tempus AI by 1.3% during the first quarter. NewEdge Advisors LLC now owns 42,996 shares of the company’s stock valued at $1,944,000 after buying an additional 536 shares during the period. Avidity Partners Management LP acquired a new stake in Tempus AI during the first quarter valued at $1,130,000. Finally, Silverback Asset Management LLC increased its holdings in Tempus AI by 44.5% in the first quarter. Silverback Asset Management LLC now owns 35,700 shares of the company’s stock valued at $1,614,000 after buying an additional 11,000 shares in the last quarter. 24.22% of the stock is owned by hedge funds and other institutional investors.

Tempus AI Company Profile

Tempus is a technology-driven healthcare company that applies artificial intelligence and machine learning to clinical and molecular data in order to advance precision medicine. Its primary focus lies in oncology, where the company offers comprehensive genomic profiling, digital pathology services and data-driven insights to inform personalized cancer care. By integrating DNA and RNA sequencing with structured clinical information, Tempus enables clinicians and researchers to identify targeted treatment options for patients based on the genetic characteristics of their tumors.

The company’s core offering centers on a scalable, cloud-based analytics platform that aggregates vast amounts of molecular and clinical data.